35916-0709-1 : NDC 2026 Code

35916-0709-1 : Acetaminophen , Aspirin And Caffeine ( Acetaminophen , Aspirin And Caffeine )

Additionally :

You can get information about “35916-0709-1” NDC code in 35916-0709-1 in HTML format

HTML | 35916-0709-1 in TXT (Plain Text) format

TXT | 35916-0709-1 in PDF (Portable Document Format)

PDF | 35916-0709-1 in XML format

XML formats.

NDC Code : 35916-0709-1 – JSON Data Format

                
{
  "NDC": {
    "NDCCode": "35916-0709-1",
    "PackageDescription": "1500 CAPSULE in 1 BAG (35916-0709-1) ",
    "NDC11Code": "35916-0709-01",
    "ProductNDC": "35916-0709",
    "ProductTypeName": "HUMAN OTC DRUG",
    "ProprietaryName": "Acetaminophen , Aspirin And Caffeine",
    "ProprietaryNameSuffix": null,
    "NonProprietaryName": "Acetaminophen , Aspirin And Caffeine",
    "DosageFormName": "CAPSULE",
    "RouteName": "ORAL",
    "StartMarketingDate": "20260108",
    "EndMarketingDate": null,
    "MarketingCategoryName": "OTC MONOGRAPH DRUG",
    "ApplicationNumber": "M013",
    "LabelerName": "Softgel Healthcare Pvt Ltd",
    "SubstanceName": "ACETAMINOPHEN; ASPIRIN; CAFFEINE",
    "StrengthNumber": "250; 250; 65",
    "StrengthUnit": "mg/1; mg/1; mg/1",
    "Pharm_Classes": "Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]",
    "DEASchedule": null,
    "Status": "Active",
    "LastUpdate": "2026-01-13",
    "PackageNdcExcludeFlag": "N",
    "ProductNdcExcludeFlag": "N",
    "ListingRecordCertifiedThrough": "20271231",
    "StartMarketingDatePackage": "20260110",
    "EndMarketingDatePackage": null,
    "SamplePackage": "N"
  }
}